🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT04506255
Recruiting Not applicable

Silicone Taping for the Improvement of Abdominal Donor Site Scars

NCT04506255 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2020-11-16
Last updated
2025-02-18

Condition(s) studied

Hypertrophic ScarScar

Investigational drug(s) / intervention(s)

Silicone tape

Silicone tape: Medical grade tape with silicone adhesive

Study summary

This study will look at silicone tape compared to the current no dressing standard at the investigators institution, to determine if silicone tape provides a significant improvement in post-abdominoplasty scar appearance. Silicone tape will be added to half of the abdominoplasty incision of patients undergoing abdominally-based breast reconstruction procedures two weeks after their operation. They will be followed up and assessed at specific timepoints to determine whether the silicone improves scar outcomes in these patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * undergoing de novo abdominoplasty procedures as part of their breast reconstruction Exclusion Criteria: * patients with a history of collagen disease, connective tissue disorders, psoriasis or lupus * patients with scleroderma * patients with a history of adverse reaction to adhesives or silicone allergy * patients with signs of dehiscence or infection resulting in modification to the experimental or control dressings * patients who are unable to care for their incisions * patients who are current smokers * patients who are currently on steroids.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Halifax Infirmary Halifax Nova Scotia Recruiting

More Nova Scotia Health Authority trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04506255 on ClinicalTrials.gov ↗ ← All trials in Canada